Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD + metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP + and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NMN and NR demonstrated protect against diabetes, Alzheimer disease, endothelial dysfunction, and inflammation.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In hyperglycaemic mice, nicotinamide riboside administration improved liver steatosis and glucose tolerance, and reduced weight gain257.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [257]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The natural source of oral NR, NAM and NA is largely the NAD+ in the food we eat as broken down by digestion and the microbiome23.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
NAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationBogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Self-citation
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
“Nevertheless, NAD boosting strategies seem to be successful in restoringmitochondrial and stem cell function (121) and in ameliorating diseases such as muscular dystrophy and diabetes (122, 123) or even prolonging life span (124).”
BackgroundNAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
“Similar protective effects were also observed in prediabetic and diabetic mice that received NR in their diet (129).”
BackgroundNAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
“NR protects mice from HFD-induced body weight gain, enhances the liver weight regain by promoting hepatocyte replication and increasing hepatic ATP content in the regenerating liver.(618) NR exhibits beneficial effects in several muscle disorders through improving mitochondrial function and decreasing the UPR in heart…”
BackgroundNAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
NAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697
Self-citationNAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588
Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake
Merz, K. E., & Thurmond, D. C. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190029 · Cited by 494
Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D. L., Zavala, E., Zhang, Y., Moritoh, K., O’Connell, J. F., Baptiste, B. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718819115 · Cited by 472
“NR reduced inflammation in mouse models of diabetes (61, 62).”
BackgroundElhassan, Y. S., Kluckova, K., Fletcher, R. S., Schmidt, M. S., Garten, A., Doig, C. L., Cartwright, D. M., Oakey, L., Burley, C. V., Jenkinson, N., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.043 · Cited by 448
Self-citationNRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13103 · Cited by 378
“NR supplementation increases lifespan in yeast, Caenorhabditis elegans and mice 20–22 and improves high-fat diet-induced metabolic complications in mice 19,23 .”
InfluentialSelf-citationRole of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
“NR significantly improved glucose tolerance, reduced weight gain, reduced hepatic steatosis, and protected against sensory neuropathy in prediabetic mice and diabetic neuropathy in T2D mice [132].”
BackgroundNicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.116.026099 · Cited by 358
Self-citationNicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Mitchell, S. J., Bernier, M., Aon, M. A., Cortassa, S., Kim, E. Y., Fang, E. F., Palacios, H. H., Ali, A., Navas-Enamorado, I., Di Francesco, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.001 · Cited by 338
“Quantitative metabolomic analysis has made it clear that oral NR boosts hepatic NAD metabolism and sirtuin activity independently of NAMPT (Ratajczak et al., 2016; Fletcher et al., 2017), thereby leading to a wave of hepatic NAM production (Trammell et al., 2016a).”
BackgroundMethodInfluentialSelf-citationRedox imbalance stress in diabetes mellitus: Role of the polyol pathway
Yan, L. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12001 · Cited by 323
“mice, and can enhance metabolism and prevent development of obesity induced by a high fat diet.(74,75) 2.”
BackgroundProgrammed axon degeneration: from mouse to mechanism to medicine
Coleman, M. P., & Höke, A. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0269-3 · Cited by 321
Dollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., et al. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy132 · Cited by 282
“NR improves glycemic control and provides resistance to weight gain, hepatic steatosis, and hypercholesterolemia in mouse models of prediabetes and diabetes (9, 35).”
BackgroundInfluentialSelf-citationNAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome
Fang, E. F., Hou, Y., Lautrup, S., Jensen, M. B., Yang, B., SenGupta, T., Caponio, D., Khezri, R., Demarest, T. G., Aman, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13172-8 · Cited by 275
Pirinen, E., Auranen, M., Khan, N. A., Brilhante, V., Urho, N., Pessia, A., Hakkarainen, A., Kuula, J., Heinonen, U., Schmidt, M. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.008 · Cited by 278
“The revelation of disturbed NAD homeostasis in muscle and metabolic diseases (Gariani et al., 2016; Khan et al., 2014; Ryu et al., 2016; Trammell et al., 2016; Yoshino et al., 2011; Zhang et al., 2016) in animals has generated a high interest whether NAD metabolism aberrations occur in degenerative diseases in humans…”
BackgroundSelf-citationNAD metabolism: Implications in aging and longevity
Yaku, K., Okabe, K., & Nakagawa, T. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.006 · Cited by 269
Nicotinamide N -Methyltransferase: More Than a Vitamin B3 Clearance Enzyme
Pissios, P. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.02.004 · Cited by 259
“gov identifiers: NCT02303483, NCT02950441) [81,82].”
Implications of altered NAD metabolism in metabolic disorders
Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0527-8 · Cited by 223
“NR (3 g/kg) Liver ↑ Improved glucose homeostasis and hepatic steatosis, suppressed body weight gain, and protective against diabetic neuropathy [10]”
BackgroundMethodThe Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Chini, E. N., Chini, C. C. S., Espindola Netto, J. M., de Oliveira, G. C., & van Schooten, W. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.001 · Cited by 227
“Experimental “NAD boosting” or “NAD replacement” can be accomplished via administration of NAD precursors such NMN, NR and derivatives of vitamin B3, or via inhibition of NAD-degrading enzymes [1-31].”
Modulating NAD + metabolism, from bench to bedside
Katsyuba, E., & Auwerx, J. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 221
“…reported that high-fat (HF)/high-fat high-sucrose (HFHS) feeding diminishes NAD + content in liver (Yoshino et al , 2011; Gariani et al , 2016, 2017; Trammell et al , 2016b), skeletal muscle (Canto et al , 2012), BAT (Canto et al , 2012), and white adipose tissue (WAT) (Yoshino et al , 2011).”
InfluentialNicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mehmel, M., Jovanović, N., & Spitz, U. (2020) · Nutrients · doi:10.3390/nu12061616 · Cited by 221
“In mice models, NR can increase NAD+ metabolism and thereby improve glucose tolerance, reduce weight gain, and exhibit neuroprotective effects against diabetic neuropathy and liver steatosis [41].”
BackgroundInfluentialNAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Conze, D., Brenner, C., & Kruger, C. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-46120-z · Cited by 210
Self-citationHepatic NADH reductive stress underlies common variation in metabolic traits
Goodman, R. P., Markhard, A. L., Shah, H., Sharma, R., Skinner, O. S., Clish, C. B., Deik, A., Patgiri, A., Hsu, Y.-H. H., Masia, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2337-2 · Cited by 205
Heer, C. D., Sanderson, D. J., Voth, L. S., Alhammad, Y. M. O., Schmidt, M. S., Trammell, S. A. J., Perlman, S., Cohen, M. S., Fehr, A. R., & Brenner, C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015138 · Cited by 192
“There is an abundance of data from model systems and humans that age and conditions of metabolic stress including obesity and type 2 diabetes (35), smoking (36), heart failure (29), nerve damage (37), and central brain injury (28) challenge the NAD system in affected tissues.”
BackgroundSelf-citationNAD+ Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter Aging
Levine, D. C., Hong, H., Weidemann, B. J., Ramsey, K. M., Affinati, A. H., Schmidt, M. S., Cedernaes, J., Omura, C., Braun, R., Lee, C., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.010 · Cited by 180
Self-citationNAD+ biosynthesis, aging, and disease
Johnson, S., & Imai, S. (2018) · F1000Research · doi:10.12688/f1000research.12120.1 · Cited by 178
Remie, C. M., Roumans, K. H., Moonen, M. P., Connell, N. J., Havekes, B., Mevenkamp, J., Lindeboom, L., de Wit, V. H., van de Weijer, T., Aarts, S. A., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa072 · Cited by 160
“Interestingly, a recently published study in obese mice showed an effect of combined supplementation of NR with l-carnitine and reported a reduction in FM percentage and hepatic steatosis (52), which matches with the positive outcome parameters of our and other studies (8, 20, 10).”
Geisler, S., Doan, R. A., Cheng, G., Cetinkaya‐Fisgin, A., Huang, S. X., Höke, A., Milbrandt, J., & DiAntonio, A. (2019) · JCI Insight · doi:10.1172/jci.insight.129920 · Cited by 148
“In addition, SARM1-KO or NR supplementation prevent paclitaxel-induced neuropathy and diabetic neuropathy in mouse models (19, 51, 52), indicating that targeting the core axon degeneration program attenuates a variety of forms of peripheral neuropathy.”
BackgroundGiroud-Gerbetant, J., Joffraud, M., Giner, M. P., Cercillieux, A., Bartova, S., Makarov, M. V., Zapata-Pérez, R., Sánchez-García, J. L., Houtkooper, R. H., Migaud, M. E., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.013 · Cited by 129
“Administration of either compound in rodents has been shown to reduce diet- and age-related metabolic complications, including insulin sensitivity [11e13], fatty liver [13,14], and kidney damage [15].”
BackgroundChandrasekaran, K., Anjaneyulu, M., Choi, J., Kumar, P., Salimian, M., Ho, C.-Y., & Russell, J. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.04.002 · Cited by 145
“One such compound is NR that is well tolerated and orally bioavailable and protects against both sensory and motor neuropathy (Trammell et al., 2016).”
BackgroundInfluentialLapatto, H. A. K., Kuusela, M., Heikkinen, A., Muniandy, M., van der Kolk, B. W., Gopalakrishnan, S., Pöllänen, N., Sandvik, M., Schmidt, M. S., Heinonen, S., et al. (2023) · Science Advances · doi:10.1126/sciadv.add5163 · Cited by 124
Self-citationFletcher, R. S., Ratajczak, J., Doig, C. L., Oakey, L. A., Callingham, R., Xavier, G. D. S., Garten, A., Elhassan, Y., Redpath, P., Migaud, M. E., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.011 · Cited by 135
“In addition, NR improves glycemic control and opposes development of diabetic neuropathy in mice and allows rats to resist development of chemotherapeutic neuropathy [24,25].”
BackgroundSelf-citationSun, X., Cao, B., Naval-Sanchez, M., Pham, T., Sun, Y. B. Y., Williams, B., Heazlewood, S. Y., Deshpande, N., Li, J., Kraus, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22863-0 · Cited by 119
Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease
Lautrup, S., Lou, G., Aman, Y., Nilsen, H., Tao, J., & Fang, E. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104469 · Cited by 105
“The effect of NR/NMN treatment on inflammation has also been confirmed in relation to diabetes (Lee et al., 2015; Trammell et al., 2016).”
Liu, H.-W., Smith, C. B., Schmidt, M. S., Cambronne, X. A., Cohen, M. S., Migaud, M. E., Brenner, C., & Goodman, R. H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809392115 · Cited by 105
“NR, commonly used to prevent conditions associated with NAD loss (20, 25, 26), protected against the vincristine-induced decrease in NAD, but generated even higher levels of NMN.”
BackgroundSelf-citationDolopikou, C. F., Kourtzidis, I. A., Margaritelis, N. V., Vrabas, I. S., Koidou, E., Kyparos, A., Theodorou, A. A., Paschalis, V., & Nikolaidis, M. G. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01919-4 · Cited by 107
Fangmann, D., Theismann, E., Türk, K., Schulte, D. M., Relling, I., Hartmann, K., Keppler, J. K., Knipp, J.-R., Rehman, A., Heinsen, F., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1967 · Cited by 113
“The NAD+ metabolome has been shown to be dysregulated in obesity and type 2 diabetes in mice (10).”
BackgroundSelf-citationWilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01060-7 · Cited by 102
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Braidy, N., & Liu, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110831 · Cited by 103
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 101
“The ubiquitous expression of NRKs, makes NR a precursor that can affect whole-body metabolism [162].”
BackgroundRole of endothelial NAD+deficiency in age-related vascular dysfunction
Csiszar, A., Tarantini, S., Yabluchanskiy, A., Balasubramanian, P., Kiss, T., Farkas, E., Baur, J. A., & Ungvari, Z. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00039.2019 · Cited by 92
Physical activity and dietary interventions in diabetic neuropathy: a systematic review
Zilliox, L. A., & Russell, J. W. (2019) · Clinical Autonomic Research · doi:10.1007/s10286-019-00607-x · Cited by 112
Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?
Koju, N., Qin, Z., & Sheng, R. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00838-7 · Cited by 100
“Quantitative metabolomics proved that hepatic NADP and NADPH levels were considerably collapsed in prediabetes and T2D but were mostly protective when mice were supplemented with NR [217].”
BackgroundCombined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., et al. (2021) · Advanced Science · doi:10.1002/advs.202101222 · Cited by 88
Dollerup, O. L., Trammell, S. A. J., Hartmann, B., Holst, J. J., Christensen, B., Møller, N., Gillum, M. P., Treebak, J. T., & Jessen, N. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01081 · Cited by 77
Self-citationVaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E., Brenner, C., & Duplus, E. (2017) · The FASEB Journal · doi:10.1096/fj.201700221rr · Cited by 86
“such precursor, nicotinamide riboside (NR), protects against diabetic peripheral neuropathy in vivo (12).”
BackgroundSelf-citationTherapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 82
Hamity, M. V., White, S. R., Walder, R. Y., Schmidt, M. S., Brenner, C., & Hammond, D. L. (2017) · Pain · doi:10.1097/j.pain.0000000000000862 · Cited by 80
“Furthermore, addition of NR to the high-fat diet of prediabetic and diabetic male mice protected against deficits in nerve conduction velocity, heat hypoalgesia, and loss of corneal and intraepidermal nerve fibers.(64) Obvious sites of action that warrant investigation include the peripheral terminals and soma of sens…”
Self-citation才原一浩, Kamikubo, R., Ikemoto, K., Uchida, K., & Akagawa, M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b01185 · Cited by 88
BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities
Yaku, K., Palikhe, S., Izumi, H., Yoshida, T., Hikosaka, K., Hayat, F., Karim, M., Iqbal, T., Nitta, Y., Sato, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27080-3 · Cited by 76
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
Fons, N. R., Sundaram, R. K., Breuer, G. A., Peng, S., McLean, R. L., Kalathil, A., Schmidt, M. S., Carvalho, D. M., Mackay, A. G., Jones, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11732-6 · Cited by 79
Self-citationMitochondria and sensory processing in inflammatory and neuropathic pain
Ribeiro, P. S. S., Willemen, H. L. D. M., & Eijkelkamp, N. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1013577 · Cited by 91
Niacin: an old lipid drug in a new NAD+ dress
Romani, M., Hofer, D. C., Katsyuba, E., & Auwerx, J. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s092007 · Cited by 74
Vreones, M. P., Mustapić, M., Moaddel, R., Pucha, K. A., Lovett, J., Seals, D. R., Kapogiannis, D., & Martens, C. R. (2022) · Aging Cell · doi:10.1111/acel.13754 · Cited by 83
“…fashion, we measured phosphoproteins involved in insulin signaling (pSer312- IRS- 1, pS473- Akt, pS9- GSK3- B, pThr421/Ser424- p70S6K, pJNK, pERK1/2, and pp38), motivated by the ability of NAD+ precursors to modulate peripheral insulin resistance (Trammell et al., 2016; Yoshino et al., 2011).”
BackgroundAntioxidant Vitamins and Ageing
Milisav, I., Ribarič, S., & Poljšak, B. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_1 · Cited by 88
Pham, T. X., Bae, M., Kim, M.-B., Lee, Y., Hu, S., Kang, H., Park, Y.-K., & Lee, J.-Y. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.009 · Cited by 73
“Reduction of body weight gain with NR supplementation is consistent with other studies [9, 11].”
ResultEar, P. H., Chadda, A., Gumusoglu, S. B., Schmidt, M. S., Vogeler, S., Malicoat, J., Kadel, J., Moore, M. M., Migaud, M. E., Stevens, H. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.007 · Cited by 72
“hepatic NADP and NADPH (Trammell et al., 2016b), we aimed to determine whether postpartum might alter the liver NAD system.”
BackgroundInfluentialSelf-citationKeeping the balance in NAD metabolism
Strømland, Ø., Niere, M., Nikiforov, A. A., VanLinden, M. R., Heiland, I., & Ziegler, M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180417 · Cited by 76
Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing
Navarro, M. N., Heras, M. M. G. D. L., & Mittelbrunn, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15477 · Cited by 82
Chandrasekaran, K., Salimian, M., Konduru, S. R., Choi, J., Kumar, P., Long, A., Klimova, N., Ho, C.-Y., Kristián, T., & Russell, J. W. (2019) · Brain · doi:10.1093/brain/awz324 · Cited by 72
“Dietary supplementation with precursors of NAD + protect against HFD-induced neuropathy (Trammell et al., 2016).”
BackgroundBoosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes
Wu, J., Singh, K., Lin, A., Meadows, A. M., Wu, K., Shing, V., Bley, M., Hassanzadeh, S., Huffstutler, R. D., Schmidt, M. S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci139828 · Cited by 76
“Because refeeding is proinflammatory (18, 19) and overfeeding disrupts hepatic NAD+ metabolism (27), we focused this study on exploring the antiinflammatory effects of NR in monocytes extracted from study participants in the refed state.”
Self-citationIdentification of evolutionary and kinetic drivers of NAD-dependent signaling
Bockwoldt, M., Houry, D., Niere, M., Gossmann, T. I., Reinartz, I., Schug, A. H., Ziegler, M., & Heiland, I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902346116 · Cited by 70
“dietary supplementation with intermediates of NAD biosynthesis, including, Nam (4), Nam mononucleotide (NMN) (16), and Nam riboside (NR) (2, 6, 17).”
BackgroundArthur‐Farraj, P., & Coleman, M. P. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01125-3 · Cited by 67
NAD + Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy
Chiao, Y. A., Chakraborty, A. D., Light, C. M., Tian, R., Sadoshima, J., Shi, X., Gu, H., & Lee, C. F. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008170 · Cited by 69
Willemen, H. L. D. M., Ribeiro, P. S. S., Broeks, M. H., Meijer, N. W. F., Versteeg, S., Tiggeler, A., de Boer, T. P., Małecki, J., Falnes, P. Ø., Jans, J. J. M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101265 · Cited by 80
“55,71 There are several mechanisms that could explain how NAD + promotes mitochondrial fitness and cellular homeostasis.”
BackgroundEmerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Matasic, D. S., Brenner, C., & London, B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00409.2017 · Cited by 66
Self-citationNAD+ in COVID-19 and viral infections
Zheng, M., Schultz, M. B., & Sinclair, D. A. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.02.001 · Cited by 62
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
Aging alters acetylation status in skeletal and cardiac muscles
Yeo, D., Kang, C., & Ji, L. L. (2020) · GeroScience · doi:10.1007/s11357-020-00171-7 · Cited by 67
“A natural NAD+ precursor, NR can be directly converted to NMN, thereby bypassing NAMPT in the salvage pathway (Trammell et al. 2016; Schöndorf et al. 2018).”
BackgroundThe therapeutic perspective of NAD+ precursors in age-related diseases
Iqbal, T., & Nakagawa, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149590 · Cited by 77
Qiao, A., Jin, X., Pang, J., Moskophidis, D., & Mivechi, N. F. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201607091 · Cited by 67
“In concordance with previous studies (Yoshino et al., 2011; Cantó et al., 2012; regulation of hepatic bioenergetics by HSF1 • Qiao et al. 735 Trammell et al., 2016), NR-treated WT mice displayed a lower blood glucose level in both the fed and fasted states (Fig.”
ResultKropotov, A., Kulikova, V., Nerinovski, K., Yakimov, A., Svetlova, M., Solovjeva, L., Sudnitsyna, J., Migaud, M. E., Khodorkovskiy, M., Ziegler, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031391 · Cited by 57
“While in some studies NR supplementation did not have beneficial effects [24–26], in others NR can efficiently enhance NAD+ levels thereby improving conditions in mouse models of diseases such as Alzheimer’s Disease [27], noise-induced hearing loss [12], high-fat diet-induced obesity [28], and type 2 diabetes [8].”
BackgroundPoly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity
Brady, P. N., Goel, A., & Johnson, M. A. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-18 · Cited by 58
“NR treatment also improved symptoms of diabetes and diabetic neuropathy in a mouse model (295).”
BackgroundNAD+ and NAFLD – caution, causality and careful optimism
Dall, M., Hassing, A. S., & Treebak, J. T. (2021) · The Journal of Physiology · doi:10.1113/jp280908 · Cited by 61
“Found that hepatocytes are CD38-negative Trammell et al. 2016a NR (100–1000 mg for humans, 185 mg/kg body weight for gavage in mice and 500 mg/kg body weight for injections in mice) 24 h (humans), 12 h (mice with gavage), and 6 days (mice with injections) Humans (healthy men and women) and Mice (male C57BL/6J at 12 we…”
BackgroundInfluentialAge-Dependent Decline of NAD+—Universal Truth or Confounded Consensus?
Peluso, A. A., Damgaard, M. V., Mori, M. A., & Treebak, J. T. (2021) · Nutrients · doi:10.3390/nu14010101 · Cited by 67
NAD+: A key metabolic regulator with great therapeutic potential
Sultani, G., Samsudeen, A., Osborne, B., & Turner, N. A. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12508 · Cited by 61
Lococo, P. M., Risinger, A. L., Smith, H. R., Chavera, T. S., Berg, K. A., & Clarke, W. P. (2017) · eLife · doi:10.7554/elife.29626 · Cited by 53
“Additionally, administration of the NAD precursor, nicotinamide riboside (NR), reduces the sensory neuropathy that occurs in diabetic mice (Trammell et al., 2016) and in female rats treated with PTX (Hamity et al., 2017).”
BackgroundNAD+ Deficits in Age-Related Diseases and Cancer
Garrido, A., & Djouder, N. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.001 · Cited by 56
Altered mitochondrial acetylation profiles in a kainic acid model of temporal lobe epilepsy
Gano, L. B., Liang, L.-P., Ryan, K., Michel, C. R., Gomez, J., Vassilopoulos, A., Reisdorph, N. A., Fritz, K. S., & Patel, M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.063 · Cited by 55
“Methods to enhance cellular levels of NAD+ are known to activate SIRT3 [33,44,70,8] and compounds found to boost cellular levels of NAD+have shown efficacy in rodent models of other neurodegenerative diseases such as Alzheimer's disease, Parkinson disease, traumatic brain injury, amyotrophic lateral sclerosis, axon de…”
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 62
“It also reduces inflammation [47,144,145], helps prevent obesity [27,53,146–148] and influences life extension [71,144,149,150].”
BackgroundEndogenous nicotinamide riboside metabolism protects against diet-induced liver damage
Sambeat, A., Ratajczak, J., Joffraud, M., Sanchez-Garcia, J. L., Giner, M. P., Valsesia, A., Giroud-Gerbetant, J., Valera-Alberni, M., Cercillieux, A., Boutant, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12262-x · Cited by 51
Role of Oxidative DNA Damage and Repair in Atrial Fibrillation and Ischemic Heart Disease
Hu, L., Wang, Z., Carmone, C., Keijer, J., & Zhang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083838 · Cited by 57
Heer, C. D., Sanderson, D. J., Voth, L. S., Alhammad, Y. M. O., Schmidt, M. S., Trammell, S. A. J., Perlman, S. M., Cohen, M. S., Fehr, A. R., & Brenner, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.17.047480 · Cited by 50
Self-citationYaku, K., Okabe, K., & Nakagawa, T. (2018) · Biomedical Chromatography · doi:10.1002/bmc.4205 · Cited by 49
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
She, J., Sheng, R., & Qin, Z. (2021) · Aging and Disease · doi:10.14336/ad.2021.0523 · Cited by 53
“It has also been shown to exert a certain ameliorating effect on alcoholinduced liver disease and depressive behaviour [28, 131, 132] and improve diabetic lesions and hepatic steatosis in mice with high-fat diet-induced obesity [133, 134].”
BackgroundLee, H. J., & Yang, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174196 · Cited by 51
“In mice, NR supplementation prevented the development of diabetic neuropathy while improving glucose tolerance in a rodent model of type 2 diabetes [33].”
BackgroundRoles of NAD + in Health and Aging
Lautrup, S., Hou, Y., Fang, E. F., & Bohr, V. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041193 · Cited by 57
Cell senescence in cardiometabolic diseases
Grootaert, M. O. J. (2024) · npj Aging · doi:10.1038/s41514-024-00170-4 · Cited by 61
Voth, L. S., O’Connor, J. J., Kerr, C. M., Doerger, E., Schwarting, N., Sperstad, P. D., Johnson, D. K., & Fehr, A. R. (2021) · Journal of Virology · doi:10.1128/jvi.00766-21 · Cited by 44
“ADP ribosylation is the posttranslational covalent addition of ADP-ribose to proteins by ADP-ribosyltransferases that utilize NAD1 as a substrate.”
BackgroundLi, W., Tong, S.-G., Yang, Z., Xiao, Y.-Q., Lv, X., Weng, Q., Yu, K., Liu, G., Luo, X., Wei, T., et al. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.10.002 · Cited by 47
Ren, Z., Xu, Y., Li, T., Sun, W., Tang, Z., Wang, Y., Zhou, K., Li, J., Ding, Q., Liang, K., et al. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2022.06.009 · Cited by 44
“It is generally believed that the optimal oral dose of NR for mice is 400mg/kg per day (Trammell et al., 2016; Gariani et al., 2016; Crisol et al., 2018, 2020; Wang et al., 2018; Pham et al., 2019).”
Background
Metadata
- Authors
- Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Iowa City VA Health Care System (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-27
- Volume
- 6
- Issue
- 1
- Pages
- 26933-26933
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4882590
- OpenAlex
- W2400466055
- Cited by
- 301
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 55 · 2021: 42 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 20 · 2016: 4
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01 BX001680, BX001680-01, BX001680, RX000889, C9251-C, RX000889-01, I01 RX000889)
- Roy J. Carver Charitable Trust
- Fraternal Order of Eagles
- National Institutes of Health (BX001680)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Institute of General Medical Sciences (T32GM008629)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081147)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide riboside, type 2 diabetes, diabetic neuropathy, NAD+ metabolism, insulin resistance, high-fat diet, streptozotocin-induced diabetes, hepatic steatosis, glucose tolerance, sensory neuropathy, corneal confocal microscopy, NADPH, neuroprotection, obesity
- MeSH terms
- Animals, Blood Glucose, Cornea, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Niacinamide, Obesity, Prediabetic State, Pyridinium Compounds, Streptozocin, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.